Wound Healing Process

Overview

Wound healing is the biological process by which damaged tissues are repaired and functional integrity is restored. This dynamic process involves the coordinated activity of multiple cell types — platelets, neutrophils, macrophages, fibroblasts, endothelial cells, and epithelial cells — operating through four overlapping phases: hemostasis, inflammation, proliferation, and remodeling. Each phase is orchestrated by specific growth factors, cytokines, and extracellular matrix interactions.

The process can result in either regeneration (restoration of original tissue architecture) or repair (replacement with scar tissue). Most adult mammalian wound healing results in scar formation, although certain tissues (liver, bone, gut epithelium) retain significant regenerative capacity.

How It Works

Phase 1: Hemostasis (Minutes)

Immediately after injury, vascular spasm and platelet aggregation at the wound site form a temporary plug. The coagulation cascade generates fibrin, which stabilizes the platelet plug into a fibrin clot. This clot serves as a provisional matrix and reservoir for growth factors (PDGF, TGF-beta, VEGF) released from platelet alpha-granules.

Phase 2: Inflammation (Hours to Days)

Neutrophils infiltrate the wound within hours, clearing bacteria and debris through phagocytosis and releasing antimicrobial peptides including LL-37 and defensins. By days 2-3, monocytes arrive and differentiate into macrophages, which phagocytose spent neutrophils and secrete growth factors that transition the wound into the proliferative phase. This phase involves activation of NF-kB signaling and pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha).

Phase 3: Proliferation (Days to Weeks)

Fibroplasia — Fibroblasts migrate into the wound, proliferate, and deposit new extracellular matrix, initially as a provisional matrix rich in fibronectin and type III collagen.

Angiogenesis — New blood vessels sprout from existing vasculature under the influence of VEGF signaling, restoring oxygen and nutrient supply to the wound bed. The vascularized, fibroblast-rich tissue is termed granulation tissue.

Epithelialization — Epithelial cells at wound margins proliferate and migrate across the granulation tissue, restoring the epithelial barrier.

Collagen synthesis — Fibroblasts produce type I and type III collagen, progressively replacing the provisional fibronectin matrix.

Phase 4: Remodeling (Weeks to Years)

The collagen matrix is reorganized: type III collagen is gradually replaced by type I collagen, cross-links form between collagen fibrils, and the scar matures. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) balance matrix degradation and deposition. Mature scar tissue achieves approximately 80% of original tissue strength.

Key Components

• Platelets — Initiate hemostasis and release growth factors
• Macrophages — Orchestrate the transition from inflammation to repair
• Fibroblasts — Produce extracellular matrix and collagen
• VEGF — Primary driver of angiogenesis in wound repair
• MMPs/TIMPs — Enzymes balancing matrix remodeling

Peptide Connections

Wound healing is one of the most actively researched areas in peptide biology:

BPC-157 (body protection compound-157) is a 15-amino-acid gastric peptide with extensive wound healing research across multiple tissue types. BPC-157 accelerates all phases of wound healing: it promotes angiogenesis through VEGF upregulation, enhances fibroblast migration and collagen deposition, reduces excessive inflammation via NF-kB modulation, and improves granulation tissue formation. Studies have demonstrated accelerated healing in skin wounds, tendon injuries, ligament damage, bone fractures, and gastrointestinal ulcers.

TB-500 (thymosin beta-4) is a 43-amino-acid peptide that promotes wound healing through cell migration, angiogenesis, and anti-inflammatory mechanisms. TB-500 sequesters G-actin monomers, promoting actin polymerization at the leading edge of migrating cells. This enhances keratinocyte and endothelial cell migration into the wound. TB-500 also downregulates inflammatory cytokines and promotes stem cell differentiation at injury sites.

GHK-Cu (glycyl-histidyl-lysine copper complex) stimulates wound healing by promoting collagen synthesis, angiogenesis, and extracellular matrix remodeling. GHK-Cu attracts macrophages and fibroblasts to wound sites, stimulates decorin production (which regulates collagen fibrillogenesis), and promotes the synthesis of glycosaminoglycans that support tissue architecture. Originally discovered as a wound healing factor in human plasma, GHK-Cu levels decline significantly with aging.

Collagen peptides provide the amino acid building blocks (glycine, proline, hydroxyproline) required for new collagen deposition during the proliferative and remodeling phases. Oral collagen peptide supplementation has been shown to increase fibroblast density and collagen fiber density in wound models.

Growth factors from the growth hormone axis support wound healing by promoting cell proliferation and protein synthesis. Growth hormone deficiency is associated with impaired wound healing, and IGF-1 directly stimulates fibroblast proliferation and collagen synthesis.

Clinical Significance

Impaired wound healing affects millions of people and represents a major healthcare burden. Chronic non-healing wounds — diabetic foot ulcers, venous leg ulcers, pressure injuries — result from persistent inflammation, inadequate angiogenesis, and impaired fibroblast function. Diabetes, vascular disease, malnutrition, aging, and immunosuppression are major risk factors.

Excessive wound healing leads to hypertrophic scars and keloids, characterized by overproduction of collagen and failure of proper remodeling. Understanding the balance between insufficient and excessive repair is essential for therapeutic intervention.

Related Topics

• Inflammation Response — The inflammatory phase of wound healing
• Collagen Synthesis — Matrix deposition during the proliferative phase
• Angiogenesis Process — New blood vessel formation in wound repair
• BPC-157 — Multi-tissue wound healing peptide
• Extracellular Matrix Remodeling — Matrix turnover during wound maturation